Page last updated: 2024-08-26

sr141716 and MPTP Neurotoxicity Syndrome

sr141716 has been researched along with MPTP Neurotoxicity Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brotchie, JM; Crossman, AR; Di Marzo, V; Fox, SH; Hill, M; Petrosino, S; van der Stelt, M	1
Bisogno, T; De Filippis, D; Di Marzo, V; Esposito, G; Iuvone, T; Petrosino, S; Scuderi, C; Steardo, L	1

Other Studies

2 other study(ies) available for sr141716 and MPTP Neurotoxicity Syndrome

Article	Year
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:9 Topics: Animals; Arachidonic Acids; Callithrix; Cannabinoid Receptor Modulators; Dyskinesia, Drug-Induced; Endocannabinoids; Female; gamma-Aminobutyric Acid; Glycerides; Levodopa; Male; MPTP Poisoning; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant	2005
Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. Journal of molecular medicine (Berlin, Germany), 2007, Volume: 85, Issue:12 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amidohydrolases; Animals; Antibodies; Apoptosis; Arachidonic Acids; Calcium; Caspase 3; Cell Communication; Cell Differentiation; Cell Proliferation; Cell Survival; Coculture Techniques; Culture Media, Conditioned; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Activation; Enzyme Inhibitors; Indoles; MPTP Poisoning; Nerve Growth Factors; Neuroglia; Neurons; Neuroprotective Agents; PC12 Cells; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; RNA Interference; RNA, Small Interfering; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Serotonin; Time Factors; Up-Regulation	2007

Article

Year

A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:9

Topics: Animals; Arachidonic Acids; Callithrix; Cannabinoid Receptor Modulators; Dyskinesia, Drug-Induced; Endocannabinoids; Female; gamma-Aminobutyric Acid; Glycerides; Levodopa; Male; MPTP Poisoning; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant

2005

Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro.

Journal of molecular medicine (Berlin, Germany), 2007, Volume: 85, Issue:12

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amidohydrolases; Animals; Antibodies; Apoptosis; Arachidonic Acids; Calcium; Caspase 3; Cell Communication; Cell Differentiation; Cell Proliferation; Cell Survival; Coculture Techniques; Culture Media, Conditioned; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Activation; Enzyme Inhibitors; Indoles; MPTP Poisoning; Nerve Growth Factors; Neuroglia; Neurons; Neuroprotective Agents; PC12 Cells; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; RNA Interference; RNA, Small Interfering; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Serotonin; Time Factors; Up-Regulation

2007